Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	41.51	83.36	58.91
Graham Fair Price	-28.66	14.13	19.80
PEG	-71.03	-0.80	2.77
Price/Book	12.49	10.03	8.91
Price/Cash Flow	180.61	146.21	52.10
Prices/Earnings	108.40	37.89	18.18
Price/Sales	22.02	23.80	19.50
Price/FCF	180.61	146.21	52.10
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-9.23	0.50	0.55
Operating Margin	-28.70	0.25	0.34
ROA	-47.22	0.01	0.02
ROE	0.12	0.07	-46.02
ROIC	0.04	0.03	-36.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-60.34
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.02	-0.36	1868.85
EPS QOQ	0.07	-0.47	619.41
FCF QOQ	0.13	-0.61	353.68
Revenue QOQ	0.02	-0.10	323.89
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	48.76	53.93	10.60
Inventory Turnover	251900000.00	0.00	inf
Debt/Capitalization	0.74	0.75	0.89
Quick Ratio	0.48	0.34	-30.34
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11.92	11.58	-2.89
Cash	0.44	0.36	-18.47
Capex	-0.45	-0.29	36.14
Free Cash Flow	2.04	0.79	-61.07
Revenue	5.45	4.88	-10.48
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.52	0.38	-27.52
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.55	23.38	33.28
Naive Interpretation	Member

06 - Financial Health · Bad

Rating